SCHEMBL7971734

SCHEMBL7971734

COc1ccc(CNc2nc(OCCO)nc3c(NCc4ccc(OC)cc4)nc(OCCO)nc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRUNE1 Q86TP1 1/20 0.60
CCNE2 O96020 8/20 0.52
CCNE1 P24864 8/20 0.52
CDK2 P24941 8/20 0.52
CDK1 P06493 4/20 0.50
PDE5A O76074 2/20 0.50
CDK5 Q00535 2/20 0.50
CDK5R1 Q15078 2/20 0.50
CCNB1 P14635 2/20 0.50
CCNT1 O60563 1/20 0.50
CCNA2 P20248 1/20 0.50
CDK7 P50613 1/20 0.50
CDK9 P50750 1/20 0.50
CCNH P51946 1/20 0.50
MNAT1 P51948 1/20 0.50
PDE4D Q08499 1/20 0.50
PDE10A Q9Y233 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CLK4 Q9HAZ1 1/20 0.46
CCNB2 O95067 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960337 0.94 PRUNE1 (0.59) PRUNE1CCNE2CCNE1CDK2CDK1
SCHEMBL7970173 0.82 TDP1 (0.54) PRUNE1CCNE2CCNE1CDK2CDK1
SCHEMBL7960318 0.81 TP53 (0.46) PRUNE1CCNE2CCNE1CDK2CDK1
SCHEMBL3682526 0.79 PRUNE1 (0.70) PRUNE1CCNE2CCNE1CDK2CDK1
SCHEMBL27221084 0.77 CCNE2 (0.71) PRUNE1CCNE2CCNE1CDK2CDK1
SCHEMBL15619030 0.75 CCNE2 (0.68) PRUNE1CCNE2CCNE1CDK2CDK1
SCHEMBL17802610 0.73 MAPT (0.47) CCNE2CCNE1CDK2CDK1PDE10A
SCHEMBL17802595 0.72 MAPT (0.47) CCNE2CCNE1CDK2CDK1PDE4D
SCHEMBL3109840 0.72 APP (0.65) CLK4
SCHEMBL3682525 0.71 PRUNE1 (0.67) PRUNE1CCNE2CCNE1CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6297250-B1 USEFUL FOR INHIBITING TRANSPORT OF NUCLEOSIDES OR PURINES ACROSS CELL MEMBRANES, THEREBY TO POTENTIATE THE ACTIVITY OF VARIOUS CYTOTOXIC ANTITUMOR DRUGS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 2001-10-02 US disclosed